image

The best stocks to buy since 1993

Latest issue now available

XL Tech Group

August 2005

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • XLT
  • Price:
  • 365p
As foreshadowed last month, XL has formed a third company, DxTech. DxTech is developing a fully-automated point-of-care device for blood testing. This technology requires just a small drop of a single reagent (making it low cost) within a disposable cartridge. It is a fully automated point-of-care device which will allow doctors to carry out an array of tests and has the potential to replace all essential biological tests currently performed at reference laboratories. Having soared since last month?s recommendation, the market was unmoved on this news. That said, XL Tech said that the market is massive with US$18 billion of clinical laboratory tests in the US alone. XL is also far down the line in developing this business with its ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe